Dis-Chem Pharmacies Past Earnings Performance
Past criteria checks 6/6
Dis-Chem Pharmacies has been growing earnings at an average annual rate of 12.8%, while the Consumer Retailing industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 10.3% per year. Dis-Chem Pharmacies's return on equity is 22.6%, and it has net margins of 2.8%.
Key information
12.8%
Earnings growth rate
12.9%
EPS growth rate
| Consumer Retailing Industry Growth | 8.2% |
| Revenue growth rate | 10.3% |
| Return on equity | 22.6% |
| Net Margin | 2.8% |
| Next Earnings Update | 30 May 2025 |
Recent past performance updates
Recent updates
Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?
Nov 27
Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value
Nov 10These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09Revenue & Expenses Breakdown
How Dis-Chem Pharmacies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Aug 24 | 37,990 | 1,061 | 1,236 | 0 |
| 31 May 24 | 37,137 | 1,023 | 1,236 | 0 |
| 29 Feb 24 | 36,283 | 984 | 1,236 | 0 |
| 30 Nov 23 | 35,237 | 942 | 1,121 | 0 |
| 31 Aug 23 | 34,191 | 899 | 1,006 | 0 |
| 31 May 23 | 33,427 | 949 | 1,006 | 0 |
| 28 Feb 23 | 32,664 | 1,000 | 1,006 | 0 |
| 30 Nov 22 | 32,231 | 1,020 | 915 | 0 |
| 31 Aug 22 | 31,798 | 1,040 | 824 | 0 |
| 31 May 22 | 31,102 | 946 | 824 | 0 |
| 28 Feb 22 | 30,407 | 853 | 824 | 0 |
| 30 Nov 21 | 29,407 | 815 | 2,894 | 0 |
| 31 Aug 21 | 28,407 | 776 | 4,964 | 0 |
| 31 May 21 | 27,343 | 722 | 4,964 | 0 |
| 28 Feb 21 | 26,278 | 669 | 4,964 | 0 |
| 30 Nov 20 | 25,611 | 655 | 4,506 | 0 |
| 31 Aug 20 | 24,944 | 641 | 4,049 | 0 |
| 31 May 20 | 24,464 | 620 | 4,049 | 0 |
| 29 Feb 20 | 23,984 | 598 | 4,049 | 0 |
| 30 Nov 19 | 23,394 | 573 | 3,748 | 0 |
| 31 Aug 19 | 22,803 | 549 | 3,448 | 0 |
| 31 May 19 | 22,111 | 634 | 3,448 | 0 |
| 28 Feb 19 | 21,420 | 719 | 3,448 | 0 |
| 30 Nov 18 | 20,898 | 718 | 3,239 | 0 |
| 31 Aug 18 | 20,376 | 718 | 3,031 | 0 |
| 31 May 18 | 19,928 | 701 | 3,031 | 0 |
| 28 Feb 18 | 19,480 | 684 | 3,031 | 0 |
| 30 Nov 17 | 18,919 | 715 | 2,831 | 0 |
| 31 Aug 17 | 18,359 | 746 | 2,631 | 0 |
| 31 May 17 | 17,814 | 679 | 2,631 | 0 |
| 28 Feb 17 | 17,268 | 612 | 2,631 | 0 |
| 30 Nov 16 | 16,794 | 548 | 1,577 | 0 |
| 31 Aug 16 | 16,320 | 484 | 524 | 0 |
| 31 May 16 | 15,691 | 498 | 524 | 0 |
| 29 Feb 16 | 15,061 | 513 | 524 | 0 |
| 28 Feb 15 | 12,911 | 434 | 2,321 | 0 |
| 28 Feb 14 | 10,321 | 409 | 1,834 | 0 |
Quality Earnings: DCP has high quality earnings.
Growing Profit Margin: DCP's current net profit margins (2.8%) are higher than last year (2.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DCP's earnings have grown by 12.8% per year over the past 5 years.
Accelerating Growth: DCP's earnings growth over the past year (18.1%) exceeds its 5-year average (12.8% per year).
Earnings vs Industry: DCP earnings growth over the past year (18.1%) exceeded the Consumer Retailing industry 15.5%.
Return on Equity
High ROE: DCP's Return on Equity (22.6%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 04:20 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/02/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dis-Chem Pharmacies Limited is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Dias | Arqaam Capital Research Offshore S.A.L. |
| Michael de Nobrega | Avior Capital Markets |
| Paul Henri Steegers | BofA Global Research |